Research & Development

Research is the Backbone of Lilly
For more than 140 years, Lilly has worked to discover medicines that make life better. From the development of insulin, the manufacture of the polio vaccine, and the discovery of medicines that treat mental illness, we have been pioneers behind breakthroughs against some of humanity’s most stubborn and devastating diseases.

We bring this same determination to our work today, uniting our expertise with the creativity of research partners across the globe to keep finding ways to make life better. This determination starts in the Lilly Research Laboratories (LRL) where more than 7,000 Lilly employees in over 50 countries work to discover and develop new medicines that will help solve our world’s greatest health challenges.

three research scientists
Clinical Research in Canada
Lilly currently has the richest mid-to-late stage pipeline in our history, representing a variety of therapeutic areas including cancer, diabetes, neuroscience and autoimmune disorders. The work to develop these molecules into medicines takes place around the world. In Canada in 2017, these Research
& Development efforts amounted to $42.1 million. Lilly Canada’s role is to help manage the clinical evaluation of potential new medicines on behalf of Lilly Global. We also provide ongoing scientific support for our marketed products to address important clinical and scientific questions.

Leading in Transparency with
Lilly understands that the health care community is looking for transparent answers that provide value to the health care decision-making process. In 2004, Lilly became the first pharmaceutical company to voluntarily launch an online clinical trial registry,

Lilly's Clinical Development Pipeline
Lilly is a company built on innovation. For a look at the unique molecules in Lilly's clinical development pipeline, please explore our interactive pipeline.